Founded by American biochemist Henrik Rhenman in 2008, Rhenman & Partners Asset Management is a Stockholm-based asset manager focusing on managing the portfolio of a niche fund registered in Luxembourg named Rhenman Healthcare Equity L/S (RHE L/S), launched in 2009.
Rhenman Healthcare Equity L/S (RHE L/S) is a long-biased global hedge fund focused on the healthcare sector. Since its inception in June 2009, RHE L/S has returned 668%, corresponding to an annual average of 17%. Rhenman Healthcare Equity L/S (RHE L/S) is led by an experienced management team, which the Scientific Advisory Board assists.
Many prestigious and notable awards have been bestowed to Rhenman & Partners Asset Management. Rhenman & Partners Asset Management was named the winner in the "Alternative Long/Short Equity Global" over three years category at the Refinitiv Lipper Fund Awards Nordics this year. Additionally, European institutional investors, high net worth people, investment consultants, fund managers, and prime brokers selected Rhenman Healthcare Equity L/S as the winner of the "Best Global Equity Hedge Fund" category of the 2021 Hedgeweek Awards.
As of the first quarter of 2022, Rhenman & Partners Asset Management invests primarily in the health sector industry.